Aprea Therapeutics (APRE) Other Non Operating Income (2018 - 2026)
Aprea Therapeutics' Other Non Operating Income came in at $440,876 for Q2 2026, up 196.1% from $148,903 a year earlier and up 209.4% from the prior quarter.
Powered by 
Analysis
Aprea Therapeutics (APRE) Other Non Operating Income (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aprea Therapeutics reported Other Non Operating Income of $915,812, down 3.2% year-over-year; for FY2025, it came in at $634,267, down 53.4% from FY2024.
- Going back by year, Other Non Operating Income was $1.36 million in FY2024 (+14.8%), $1.19 million in FY2023 (+62.3%), $730,201 in FY2022 (+128.9%) and $319,050 in FY2021.
- The Q2 2026 figure represents the highest quarterly Other Non Operating Income since Q1 2021.
- Year-over-year, Other Non Operating Income increased in two of the last eight quarters, with growth averaging 2.3%.
- The fastest year-over-year change in Other Non Operating Income over five years came in Q2 2026 (growth of 196.1%), and the weakest in Q1 2022 (a decline of 73.5%).
- Business Quant data shows APRE's Other Non Operating Income at $142,495 (Q1 2026), $187,463 (Q4 2025) and $144,978 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Aprea Therapeutics | 37.44 Mn | 37.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 440,876.00 |
| Mar 31, 2026 | 142,495.00 |
| Dec 31, 2025 | 187,463.00 |
| Sep 30, 2025 | 144,978.00 |
| Jun 30, 2025 | 148,903.00 |
| Mar 31, 2025 | 152,923.00 |
| Dec 31, 2024 | 331,246.00 |
| Sep 30, 2024 | 313,247.00 |
| Jun 30, 2024 | 376,872.00 |
| Mar 31, 2024 | 339,579.00 |
| Dec 31, 2023 | 231,675.00 |
| Sep 30, 2023 | 318,335.00 |
| Jun 30, 2023 | 392,584.00 |
| Mar 31, 2023 | 242,613.00 |
| Dec 31, 2022 | 209,486.00 |
| Sep 30, 2022 | 175,476.00 |
| Jun 30, 2022 | 207,057.00 |
| Mar 31, 2022 | 138,182.00 |
| Dec 31, 2021 | 71,817.00 |
| Sep 30, 2021 | -21,940.00 |
API Access
Aprea Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=APRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();